medecolМедицина и экологияMedicine and ecology2305-60452305-6053Карагандинский медицинский университет10.59598/ME-2305-6045-2024-113-4-159-164medecol-814Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИCLINICAL CASESСлучай эмболии околоплодными водами, успешно вылеченный с помощью мультидисциплинарного леченияThe case of amniotic fluid embolism successfully cured by multidisciplinary treatmentКулбаеваС. Н.KulbayevaS. N.

Салтанат Налибеккызы Кулбаева

160019, г. Шымкент, пл. Аль-Фараби 1

Saltanat Nalibekkyzy Kulbayeva

160019, Shymkent, Al-Farabi square 1

saltanat_phd@mail.ruШариповаХ. К.SharipovaKh. K.

010000, г. Астана, ул.Бейбитшилик, 49 а

010000, Astana, Beibitshilik str., 49a

mail@amu.kzШтобзаО. С.ShtobzaO. S.

160019, г. Шымкент, пл. Аль-Фараби 1

160019, Shymkent, Al-Farabi square 1

info@skma.kzАхметоваН. Н.AkhmetovaN. N.

160019, г. Шымкент, пл. Аль-Фараби 1

160019, Shymkent, Al-Farabi square 1

info@skma.kzТурганбаеваЖ. А.TurganbayevaJ. A.

160019, г. Шымкент, пл. Аль-Фараби 1

160019, Shymkent, Al-Farabi square 1

info@skma.kzАО «Южно-Казахстанская медицинская академия»КазахстанJSC «South Kazakhstan Medical Academy»KazakhstanМедицинский университет АстанаКазахстанAstana Medical UniversityKazakhstanАО «Южно-Казахстанская медицинская академияКазахстанJSC «South Kazakhstan Medical Academy»Kazakhstan20242301202504159164Copyright © Кулбаева С.Н., Шарипова Х.К., Штобза О.С., Ахметова Н.Н., Турганбаева Ж.А., 20242024Кулбаева С.Н., Шарипова Х.К., Штобза О.С., Ахметова Н.Н., Турганбаева Ж.А.Kulbayeva S.N., Sharipova K.K., Shtobza O.S., Akhmetova N.N., Turganbayeva J.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medecol.qmu.kz/jour/article/view/814

Представлен клинический случай как пример возможного пути снижения материнской смертности от эмболии околоплодными водами, своевременной диагностики и лечение с целью сохранения жизни матери.Описан клинический случай эмболии околоплодными водами, успешно вылеченный с помощью мультидисциплинарного лечения в РГП на ПХВ «Областной перинатальный центр №1» (Туркестанская область, Казахстан) в 2024 г.Были своевременно проведены дополнительные обследования: электрокардиограммы, эхокардиографии, рентгенография органов грудной клетки, консультации специалистов: терапевта, окулиста, невролога, кардиолога. Своевременно был проведен мультидисциплинарный консилиум с узкими специалистами и по рекомендациям консультантов проведена коррекция в назначениях. Медицинская бригада и анестезиологи сыграли большую роль в спасении жизни матери.Представленный клинический случай демонстрирует, что акушер-гинеколог и реаниматологи должны обратить внимание на оценку наличия предрасполагающих факторов развития эмболии околоплодными водами у каждой конкретной роженицы.

The authors present the clinical case as an example of a possible way to reduce maternal mortality from amniotic fluid embolism, timely diagnosis and treatment in order to save the mother's life.The study describes a rare clinical case of amniotic fluid embolism, successfully cured with the help of multi-disciplinary treatment, which was treated at the RSE at the Regional Perinatal Center No. 1 (Turkestan region, Kazakhstan) in 2024.Additional examinations were carried out in a timely manner: electrocardiograms, echocardiography, chest X-ray, specialist consultations: a therapist, an optometrist, a neurologist, a cardiologist. A multidisciplinary consultation with narrow specialists was held in a timely manner and, according to the recommendations of consultants; a correction in appointments was carried out. The medical team and anesthesiologists played a big role in saving the mother's life.The presented clinical case shows that obstetricians, gynecologists, and intensive care specialists should pay attention to assessing the presence of predisposing factors for the development of EOV in each individual.

эмболия околоплодными водамианафилактоидный синдром беременностиматеринская заболеваемостьматеринская смертностьamniotic fluid embolismanaphylactoid pregnancy syndromematernal morbiditymaternal mortalityReferencesBenson M. D. Current concepts of immunology and diagnosis in amniotic fluid embolism /Clin. Dev. Immunol. – 2012. – V. 201. – 946576.Benson M. D. Current concepts of immunology and diagnosis in amniotic fluid embolism /Clin. Dev. Immunol. – 2012. – V. 201. – 946576.Clark S. L. Amniotic fluid embolism //Obstet. Gynecol. – 2014. – V. 123. – P. 337-348.Clark S. L. Amniotic fluid embolism //Obstet. Gynecol. – 2014. – V. 123. – P. 337-348.Driessen M. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity /M. Driessen, M. H. Bouvier-Colle, C. Dupont //Obstet. Gynecol. – 2011. – V. 117. – P. 21-31.Driessen M. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity /M. Driessen, M. H. Bouvier-Colle, C. Dupont //Obstet. Gynecol. – 2011. – V. 117. – P. 21-31.Hasegawa J. Current status of pregnancyrelated maternal mortality in Japan: a report from the maternal death exploratory committee in Japan /J. Hasegawa, A. Sekizawa, H. Tanaka //BMJ Open. – 2016. – V. 6. – P. 1-8.Hasegawa J. Current status of pregnancyrelated maternal mortality in Japan: a report from the maternal death exploratory committee in Japan /J. Hasegawa, A. Sekizawa, H. Tanaka //BMJ Open. – 2016. – V. 6. – P. 1-8.Kanayama N. Amniotic fluid embolism: pathophysiology and new strategies for management /N. Kanayama, N. Tamura //J. Obstet. Gynaecol. Res. – 2014. – V. 40. – P. 1507-1517.Kanayama N. Amniotic fluid embolism: pathophysiology and new strategies for management /N. Kanayama, N. Tamura //J. Obstet. Gynaecol. Res. – 2014. – V. 40. – P. 1507-1517.Kanayama N. Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism /N. Kanayama, J. Inori, H. Ishibashi-Ueda //J. Obstet. Gynaecol. Res. – 2011. – V. 37. – P. 58-63.Kanayama N. Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism /N. Kanayama, J. Inori, H. Ishibashi-Ueda //J. Obstet. Gynaecol. Res. – 2011. – V. 37. – P. 58-63.Knight M. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations /M. Knight, C. Berg, P. Brocklehurst //BMC Pregnancy Childbirth. – 2012. – V. 12. – P. 7.Knight M. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations /M. Knight, C. Berg, P. Brocklehurst //BMC Pregnancy Childbirth. – 2012. – V. 12. – P. 7.Kobayashi T. Obstetrical disseminated intravascular coagulation score //J. Obstet. Gynaecol. Res. – 2014. – V. 40 (6). – P. 1500-1506.Kobayashi T. Obstetrical disseminated intravascular coagulation score //J. Obstet. Gynaecol. Res. – 2014. – V. 40 (6). – P. 1500-1506.Kramer M. S. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study /M. S. Kramer, J. Rouleau, T. F. Baskett //Lancet. – 2006. – V. 368. – P. 1444-1448.Kramer M. S. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study /M. S. Kramer, J. Rouleau, T. F. Baskett //Lancet. – 2006. – V. 368. – P. 1444-1448.Paolo Busardò F. Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools /F. Paolo Busardò, P. Frati, S. Zaami //Int. J. Mol. Sci. – 2015. – V. 16. – P. 6557-6570.Paolo Busardò F. Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools /F. Paolo Busardò, P. Frati, S. Zaami //Int. J. Mol. Sci. – 2015. – V. 16. – P. 6557-6570.Sultan P. Amniotic fluid embolism: update and review /P. Sultan, K. Seligman, B. Carvalho //Curr. Opin. Anaesthesiol. – 2016. – V. 29. – P. 288-296.Sultan P. Amniotic fluid embolism: update and review /P. Sultan, K. Seligman, B. Carvalho //Curr. Opin. Anaesthesiol. – 2016. – V. 29. – P. 288-296.Tamura N. C1 esterase inhibitor activity in amniotic fluid embolism /N. Tamura, S. Kimura, M. Farhana //Crit. Care Med. – 2014. – V. 42. – P. 1392-1396.Tamura N. C1 esterase inhibitor activity in amniotic fluid embolism /N. Tamura, S. Kimura, M. Farhana //Crit. Care Med. – 2014. – V. 42. – P. 1392-1396.

The authors declare that there are no conflicts of interest present.